相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel KMT2D mutation resulting in Kabuki syndrome: A case report
Jun Lu et al.
MOLECULAR MEDICINE REPORTS (2016)
CLPB Mutations Cause 3-Methylglutaconic Aciduria, Progressive Brain Atrophy, Intellectual Disability, Congenital Neutropenia, Cataracts, Movement Disorder
Saskia B. Wortmann et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations
Jason A. O'Rawe et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies
Guntram Borck et al.
GENOME RESEARCH (2015)
Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development
Peter M. Van Laarhoven et al.
HUMAN MOLECULAR GENETICS (2015)
RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome
Nina Boegershausen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen
Anita Ordas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Kabuki syndrome: clinical and molecular diagnosis in the first year of life
Maria Lisa Dentici et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation
Piotr Rutkowski et al.
EXPERT OPINION ON DRUG SAFETY (2014)
A Novel Ribosomopathy Caused by Dysfunction of RPL10 Disrupts Neurodevelopment and Causes X-Linked Microcephaly in Humans
Susan S. Brooks et al.
GENETICS (2014)
Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome
Hans T. Bjornsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
MLL2 and KDM6A Mutations in Patients With Kabuki Syndrome
Noriko Miyake et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
The RASopathies
Katherine A. Rauen
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 14 (2013)
Unmasking Kabuki syndrome
N. Boegershausen et al.
CLINICAL GENETICS (2013)
Dabrafenib: First Global Approval
Anita D. Ballantyne et al.
DRUGS (2013)
Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies
Geoffrey T. Gibney et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
KDM6A Point Mutations Cause Kabuki Syndrome
Noriko Miyake et al.
HUMAN MUTATION (2013)
B-Raf and the inhibitors: from bench to bedside
Tiangui Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Metabolism and Disposition of Oral Dabrafenib in Cancer Patients: Proposed Participation of Aryl Nitrogen in Carbon-Carbon Bond Cleavage via Decarboxylation following Enzymatic Oxidation
David A. Bershas et al.
DRUG METABOLISM AND DISPOSITION (2013)
Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in Three Patients with Kabuki Syndrome
Damien Lederer et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
ERK Inhibition Rescues Defects in Fate Specification of Nf1-Deficient Neural Progenitors and Brain Abnormalities
Yuan Wang et al.
CELL (2012)
Retrospective outcomes studies for orphan diseases: challenges and opportunities
Peter Sun et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum
Siddharth Banka et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
OTX2 mutations contribute to the otocephaly-dysgnathia complex
Nicolas Chassaing et al.
JOURNAL OF MEDICAL GENETICS (2012)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET (2012)
A mutation screen in patients with Kabuki syndrome
Yun Li et al.
HUMAN GENETICS (2011)
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation
Xue Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome
Sarah B. Ng et al.
NATURE GENETICS (2010)
The Basics of Brain Development
Joan Stiles et al.
NEUROPSYCHOLOGY REVIEW (2010)
Sec24D-Dependent Transport of Extracellular Matrix Proteins Is Required for Zebrafish Skeletal Morphogenesis
Swapnalee Sarmah et al.
PLOS ONE (2010)
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
William E. Tidyman et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
A Central Role for Decorin during Vertebrate Convergent Extension
Jason J. Zoeller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome
Carmen C. Leitch et al.
NATURE GENETICS (2008)
Zebrafish based assays for the assessment of cardiac, visual and gut function — potential safety screens for early drug discovery
Stéphane Berghmans et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2008)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
Kabuki syndrome: Clinical data in 20 patients, literature review, and further guidelines for preventive management
CTRM Schrander-Stumpel et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)
Kabuki make-up syndrome: A review
N Matsumoto et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Kabuki syndrome: a review study of three hundred patients
MW Wessels et al.
CLINICAL DYSMORPHOLOGY (2002)
Rap1 signalling: Adhering to new models
JL Bos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
